The store will not work correctly when cookies are disabled.
7-(4-(Aminomethyl)phenyl)-4-methylquinolin-2-amine Dihydrochloride
ID: ALA4522356
PubChem CID: 155543079
Max Phase: Preclinical
Molecular Formula: C17H19Cl2N3
Molecular Weight: 263.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(N)nc2cc(-c3ccc(CN)cc3)ccc12.Cl.Cl
Standard InChI: InChI=1S/C17H17N3.2ClH/c1-11-8-17(19)20-16-9-14(6-7-15(11)16)13-4-2-12(10-18)3-5-13;;/h2-9H,10,18H2,1H3,(H2,19,20);2*1H
Standard InChI Key: DNMFGAGUZLYUHT-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 22 0 0 0 0 0 0 0 0999 V2000
7.1442 -19.9510 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.2372 -16.9670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2361 -17.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9483 -18.2038 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9465 -16.5581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6592 -16.9634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6600 -17.7865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3727 -18.1977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0850 -17.7828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0803 -16.9565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3671 -16.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5239 -18.2028 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9441 -15.7409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7908 -18.1846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7934 -19.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5022 -19.4080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2089 -18.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2023 -18.1745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4930 -17.7731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9191 -19.4002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6243 -18.9873 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5057 -19.3938 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
3 12 1 0
5 13 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
9 14 1 0
17 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.34 | Molecular Weight (Monoisotopic): 263.1422 | AlogP: 3.25 | #Rotatable Bonds: 2 |
Polar Surface Area: 64.93 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.27 | CX LogP: 3.18 | CX LogD: 1.24 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.75 | Np Likeness Score: -0.29 |
References
1. Cinelli MA, Reidl CT, Li H, Chreifi G, Poulos TL, Silverman RB.. (2020) First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate., 63 (9): [PMID:32302123] [10.1021/acs.jmedchem.9b01573] |